This page is being served from the Urological Sciences Research Foundation web repository, and was originally posted between 1996-2008. In January 2009 USRF’s founder, Dr. Leonard S. Marks and his staff joined UCLA’s Department of Urology where they are continuing their research. Click for more information.

this is a navigational image map, please load this image to continue.
Next Last Index Home
Slide 16 of 18
Kaplan showed that the protective effect of 5ARI drugs extended across the symptom spectrum, ie, even men with mild symptoms were at risk if they had large prostates; thus the risk reduction from the 5ARI drugs applied meaningfully to men on the left side of the chart (few symptoms) as well as on the right side (many symptoms).

this is a navigational image map, please load this image to continue.